BusinessAptose to Present New CG’806 Data at the 2017 ASH Annual MeetingBy Nasdaq OMXNov 1, 2017, 3:14 PM UTC
BusinessActinium Pharmaceuticals Announces Multiple Posters/Abstracts Accepted for 59th Annual American Society of Hematology Meeting Highlighting Company’s Drug Candidates and Technology PlatformBy Nasdaq OMXNov 1, 2017, 1:05 PM UTC
BusinessActinium Pharmaceuticals Announces Activation of Fifteenth Clinical Trial Site in the Phase 3 SIERRA Trial for Iomab-BBy Nasdaq OMXOct 25, 2017, 11:30 AM UTC
BusinessActinium Pharmaceuticals Provides Update on Actimab-A Phase 2 Clinical Trial for Patients with Acute Myeloid LeukemiaBy Nasdaq OMXOct 4, 2017, 11:30 AM UTC
BusinessActinium Pharmaceuticals to Participate in American Society for Blood and Marrow Transplantation 2017 Corporate Council MeetingBy Nasdaq OMXSep 20, 2017, 11:30 AM UTC
BusinessActinium Pharmaceuticals Highlights Presence at the Society of Hematologic Oncology 2017 Annual MeetingBy Nasdaq OMXSep 13, 2017, 11:30 AM UTC
BusinessAptose Biosicences and CrystalGenomics Announce Issuance of U.S. Patent for CG’806By Nasdaq OMXSep 12, 2017, 12:01 PM UTC
BusinessActinium to Present at The Rodman & Renshaw 19th Annual Global Investment ConferenceBy Nasdaq OMXSep 6, 2017, 8:05 PM UTC
